Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Rouaz, Khadija et al., 2021
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/176690

Excipients in the Paediatric Population: A Review

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Related resource

Abstract

This theoretical study seeks to critically review the use of excipients in the paediatric population. This study is based on the rules and recommendations of European and American drug regulatory agencies. On the one hand, this review describes the most frequent excipients used in paediatric medicine formulations, identifying the compounds that scientific literature has marked as potentially harmful regarding the side effects generated after exposure. On the other hand, this review also highlights the importance of carrying out safety -checks on the excipients, which, in most cases, are linked to toxicity studies. An excipient in the compilation of paediatric population databases is expected to target safety and toxicity, as in the STEP database. Finally, a promising pharmaceutical form for child population, ODT (Orally Disintegrating Tablets), will be studied.

Citation

Citation

ROUAZ EL HAJOUI, Khadija, et al. Excipients in the Paediatric Population: A Review. Pharmaceutics. 2021. Vol. 13, num. 3, pags. 387. ISSN 1999-4923. [consulted: 14 of August of 2026]. Available at: https://hdl.handle.net/2445/176690

Export metadata

JSON - METS

Share record